As part of the other fraudulent scheme, Walgreens used its Prescription Savings Program to overcharge federal health care programs, according to prosecutors. (Photo: Shutterstock)
Walgreens has entered into an agreement with federal prosecutors in Manhattan to settle Medicaid and Medicare fraud allegations in two separate actions brought against the national pharmacy chain, according to court records unsealed by U.S. District Judge Paul Crotty of the Southern District of New York Tuesday.
The company agreed to pay more than $209 million to resolved that it improperly billed federal health care programs for hundreds of thousands of insulin pens provided to Medicare and Medicaid beneficiaries who did not need the diabetes medication. Additionally, Walgreen's agreed to a $60 million payment for overbilling Medicaid for medications offered to consumers through a discount program.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Colby Hamilton
B. Colby Hamilton is a litigation reporter for the New York Law Journal and Law.com.
